Breakdown | |||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|
Income Statement | Total Revenue | ||
3.23B | 2.68B | 2.70B | 2.03B | Gross Profit |
3.00B | 2.57B | 2.57B | 1.88B | EBIT |
111.00M | 671.00M | 633.00M | 239.00M | EBITDA |
279.00M | 855.00M | 865.00M | 443.00M | Net Income Common Stockholders |
306.00M | 524.00M | 549.00M | 388.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||
2.92B | 2.21B | 1.64B | 0.00 | Total Assets |
7.93B | 6.87B | 6.51B | 0.00 | Total Debt |
226.00M | 219.00M | 261.00M | 0.00 | Net Debt |
-1.70B | -1.33B | -743.00M | 0.00 | Total Liabilities |
2.63B | 2.81B | 2.96B | 0.00 | Stockholders Equity |
5.29B | 4.05B | 3.55B | 0.00 |
Cash Flow | Free Cash Flow | ||
947.00M | 646.00M | 383.00M | 1.07B | Operating Cash Flow |
1.09B | 739.00M | 458.00M | 1.23B | Investing Cash Flow |
-516.00M | -138.00M | -619.00M | -340.00M | Financing Cash Flow |
-208.00M | -42.00M | -32.00M | -789.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | $790.25B | 22.70 | 32.11% | 1.12% | 35.45% | ― | |
76 Outperform | $153.61B | 14.20 | 42.21% | 2.43% | 16.15% | 32.28% | |
75 Outperform | $159.47B | 98.31 | 3.90% | ― | 21.71% | 99.00% | |
71 Outperform | $129.05B | 161.55 | 14.11% | ― | 25.73% | 865.12% | |
71 Outperform | $98.50B | 63.33 | 4.43% | 1.92% | -19.28% | -44.00% | |
60 Neutral | $10.77B | 10.41 | -6.71% | 2.99% | 7.69% | -13.12% | |
43 Neutral | $86.98B | ― | -18.66% | 2.51% | -3.97% | -562.40% |